Bae Jun Yong, Ryu Chang Beom, Lee Moon Sung, Dimitriadis Stavros
Digestive Disease Center, Department of Internal Medicine, Seoul Medical Center, Seoul 02053, Republic of Korea.
Digestive Disease Center and Research Institute, Department of Internal Medicine, SoonChunHyang University School of Medicine, Bucheon 14584, Republic of Korea.
Cancers (Basel). 2025 Feb 10;17(4):602. doi: 10.3390/cancers17040602.
To treat early gastric cancer, one must choose between endoscopic treatment and surgical treatment. Endoscopic treatment has been developing significantly since the late 1990s and has made great progress up to the present. However, many patients with early gastric cancer still undergo unnecessary surgery or endoscopic procedures. This is due to the existence of a "gray zone" of ambiguities between endoscopic and surgical treatment. These ambiguities arise because the important factors in determining the treatment for early gastric cancer can only be fully understood after endoscopic or surgical resection or because of discrepancies between the factors identifiable before treatment and those identifiable after treatment. This article aims to explore these ambiguous factors and discuss methods and efforts to reduce them.
对于早期胃癌的治疗，必须在内镜治疗和手术治疗之间做出选择。自20世纪90年代末以来，内镜治疗有了显著发展，至今已取得了很大进展。然而，许多早期胃癌患者仍接受了不必要的手术或内镜检查。这是由于内镜治疗和手术治疗之间存在一个模糊的“灰色地带”。这些模糊性的出现是因为决定早期胃癌治疗的重要因素只有在内镜或手术切除后才能完全理解，或者是因为治疗前可识别的因素与治疗后可识别的因素之间存在差异。本文旨在探讨这些模糊因素，并讨论减少这些因素的方法和措施。
Zotero 插件
